Kimiaki Utsugisawa Selected Research

Interferon-alpha (Interferon Alfa)

6/2005

[Hypothyroid myopathy caused by interferon-alpha therapy for chronic hepatitis C].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimiaki Utsugisawa Research Topics

Disease

31	Myasthenia Gravis 05/2021 - 01/2002
9	Thymoma (Thymic Carcinoma) 01/2021 - 08/2007
4	Thymus Hyperplasia 01/2018 - 01/2003
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 07/2011
3	Myocarditis (Carditis) 09/2013 - 08/2007
3	Hypoxia (Hypoxemia) 04/2005 - 05/2002
2	Muscle Weakness 05/2021 - 01/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2009 - 08/2007
2	Guillain-Barre Syndrome 09/2006 - 01/2003
1	Meningococcal Infections 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Meningococcal Meningitis 12/2017
1	Thymus Neoplasms (Thymus Neoplasm) 12/2017
1	Headache (Headaches) 12/2017
1	Osteoporotic Fractures 01/2015
1	Osteoporosis 01/2015
1	Heart Diseases (Heart Disease) 09/2013
1	Taste Disorders (Taste Disorder) 09/2013
1	Pure Red-Cell Aplasia 09/2013
1	Isaacs Syndrome (Neuromyotonia) 09/2013
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2013
1	Alopecia Areata 09/2013
1	Hypertension (High Blood Pressure) 01/2012
1	Blepharoptosis (Ptosis, Eyelid) 07/2011
1	Rhabdomyosarcoma 08/2007
1	Hyperplasia 07/2007
1	Hypesthesia (Numbness) 09/2006
1	Herpes Zoster 09/2006
1	Chronic Hepatitis C 06/2005
1	Muscular Diseases (Myopathy) 06/2005
1	Hypothyroidism 06/2005
1	Hepatitis A (Hepatitis, Infectious) 01/2003
1	Pheochromocytoma 05/2002

Drug/Important Bio-Agent (IBA)

13	Cholinergic ReceptorsIBA 05/2021 - 01/2003
9	AutoantibodiesIBA 05/2021 - 08/2007
7	AntibodiesIBA 01/2018 - 01/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 01/2011
5	eculizumab FDA Link 01/2021 - 12/2017
5	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 01/2005
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 09/2006
3	glucose-mannose-glucoseIBA 05/2021 - 01/2019
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2013 - 11/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 01/2010
3	Calcineurin InhibitorsIBA 01/2012 - 02/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 02/2010 - 02/2003
2	Complement System Proteins (Complement)IBA 01/2021 - 12/2017
2	SteroidsIBA 01/2020 - 01/2010
2	Complement Inactivating AgentsIBA 12/2019 - 12/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 09/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2011 - 11/2009
2	ConnectinIBA 01/2011 - 11/2009
2	Methylprednisolone FDA LinkGeneric 01/2011 - 01/2002
2	phytobacteriomycin (PBM)IBA 02/2003 - 01/2003
2	PhytohemagglutininsIBA 02/2003 - 01/2003
2	Interleukin-2 (IL2)IBA 02/2003 - 01/2003
1	zilucoplanIBA 05/2021
1	Complement C5 (Complement 5)IBA 05/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin Fc FragmentsIBA 01/2021
1	margatoxinIBA 09/2019
1	Rituximab (Mabthera)FDA Link 12/2017
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 11/2016
1	GlucocorticoidsIBA 01/2015
1	AutoantigensIBA 09/2013
1	Immunologic Factors (Immunomodulators)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 09/2012
1	CreatinineIBA 01/2012
1	glucose-regulated proteinsIBA 08/2011
1	Naphazoline (All Clear)FDA LinkGeneric 07/2011
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2011
1	EpitopesIBA 01/2011
1	Muscle Proteins (Muscle Protein)IBA 01/2011
1	2-methylphenyl cinnamateIBA 01/2010
1	SulfurIBA 08/2007
1	AntigensIBA 07/2007
1	Protein Kinase CIBA 07/2007
1	Protein Kinase C-thetaIBA 07/2007
1	Interferon-alpha (Interferon Alfa)IBA 06/2005
1	thyrotropin-binding inhibitory immunoglobulinIBA 06/2005
1	Thyroid HormonesIBA 06/2005
1	Angiotensin IIIBA 04/2005
1	HLA-DR Antigens (HLA-DR)IBA 05/2003
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2003
1	Neuroprotective AgentsIBA 11/2002
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 05/2002
1	Nicotine FDA Link 05/2002

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2002
6	Thymectomy 09/2019 - 01/2003
4	Activities of Daily Living (ADL) 01/2021 - 12/2017
2	Plasmapheresis 01/2021 - 01/2011
1	Plasma Exchange 12/2017
1	Adjuvant Radiotherapy 05/2013
1	Immunomodulation 11/2009
1	Aftercare (After-Treatment) 01/2005